Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flinn

Showing results (831-840 of 1,038) with videos related to

Pageof 104
Sort By:
Clinical and Experimental Rheumatology|September 25, 2007
Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritisP Alex, P Szodoray, N Knowlton, et al.
Cancers|July 2, 2021
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose LevelsRichard L Wahl, Eric C Frey, Heather A Jacene, et al.
Blood|January 17, 2004
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletionsGerard Lozanski, Nyla A Heerema, Ian W Flinn, et al.
Blood|October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Thomas J Kipps, Ian W Flinn, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomesMichael A Flinn, Santiago Alvarez-Argote, Makenna C Knas, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
JCI Insight|December 5, 2023
IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophagesSantiago Alvarez-Argote, Samantha J Paddock, Michael A Flinn, et al.
Journal of Animal Science|November 18, 2020
Supplementing Merino ewes with melatonin during the last half of pregnancy improves tolerance of prolonged parturition and survival of second-born twin lambsTom Flinn, Niki L McCarthy, Alyce M Swinbourne, et al.
Leukemia & Lymphoma|October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemiaThomas S Lin, Wendy Stock, Huiping Xu, et al.
British Journal of Haematology|May 23, 2013
Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 studyNeil P Shah, Moshe Talpaz, Michael W N Deininger, et al.
Pageof 104

Showing results (831-840 of 1,038) with videos related to

Sort By:
Pageof 104
Clinical and Experimental Rheumatology|September 25, 2007
Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritisP Alex, P Szodoray, N Knowlton, et al.
Cancers|July 2, 2021
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose LevelsRichard L Wahl, Eric C Frey, Heather A Jacene, et al.
Blood|January 17, 2004
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletionsGerard Lozanski, Nyla A Heerema, Ian W Flinn, et al.
Blood|October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemiaJohn C Byrd, Thomas J Kipps, Ian W Flinn, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomesMichael A Flinn, Santiago Alvarez-Argote, Makenna C Knas, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
JCI Insight|December 5, 2023
IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophagesSantiago Alvarez-Argote, Samantha J Paddock, Michael A Flinn, et al.
Journal of Animal Science|November 18, 2020
Supplementing Merino ewes with melatonin during the last half of pregnancy improves tolerance of prolonged parturition and survival of second-born twin lambsTom Flinn, Niki L McCarthy, Alyce M Swinbourne, et al.
Leukemia & Lymphoma|October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemiaThomas S Lin, Wendy Stock, Huiping Xu, et al.
British Journal of Haematology|May 23, 2013
Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 studyNeil P Shah, Moshe Talpaz, Michael W N Deininger, et al.
Pageof 104